Medicines at
the Nexus of
Metabolism &
Immunity
"Path to End Patient Suffering"
Medicines at
the Nexus of
Metabolism &
Immunity
"Path to End Patient Suffering"
Medicines at
the Nexus of
Metabolism &
Immunity
"Path to End Patient Suffering"
Previous
Next

Medicines at the Nexus of Metabolism Immunity

“Path to End Patient Suffering”

Nirogy Story & Vision

“Nirogy” means “without illness” in Sanskrit. Our vision is to create a path to end patient suffering. Nirogy has been trying to unravel the intricate symbiotic communication network among various cell types in the tumor and immune microenvironment (TIME)…

Transformative Science

A pioneer in the metabolic solute carrier transporter (SLCT) space, a largely untapped target class, for hard-to-treat diseases such as cancer, autoimmunity, and inflammation…

Executive Team

An experienced team of science, business, and operations united by a common goal.

Nirogy News

Press Releases

Nirogy Therapeutics to Present at AACR Annual Meeting 2022

Two posters highlighting preclinical data of a small molecule development candidate with a novel mechanism of immune activation in the TME and cancer cell intrinsic killing demonstrate significant efficacy across …

Read More →
Company News

Nirogy Therapeutics Presented at Keystone Symposia on Cancer Immunotherapy: Decoding the Cancer Immunity Interactome. British Columbia, CANADA

Framingham, MA, March 30, 2022, Nirogy Therapeutics, a biopharmaceutical company focused on oncology and Immune diseases, presented at the Cancer Immunotherapy: Decoding the cancer immunity interactome, Keystone Conference that took …

Read More →
Company News

Nirogy Therapeutics Appoints Simon Pedder, Ph.D., as Chief Executive Officer

Appointment Strengthens Leadership and Expertise to Drive Lead Oncology Program into Phase 1 Clinical Development Founding Chief Executive Officer Dr. Vincent Sandanayaka transitions to role of President and Chief Scientific …

Read More →
Scroll to Top

This website uses cookies to ensure you get the best experience on our website.

Vincent P. Sandanayaka, Ph.D.

FOUNDER

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat